Pune, India -- (SBWIRE) -- 04/26/2018 -- Global Self-Injections Market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at a CAGR of 22.6% in the forecast period 2017 to 2024.

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-self-injections-market

This report consists of below pages:

- No of pages: 350
- No of Figures: 60
- No of Tables: 220

Competitive Landscape:

The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Top Companies Mentioned:

- Abbvie, Inc.
- Antares Pharma
- 3M
- Becton Dickinson & Company
- Baxter International Inc.
- Penjet Corporation
- PharmaJet
- GerresheimerAG
- Pfizer Inc.
- Terumo Corporation
- Mylan N.V.
- SHL Group
- Bespak
- Janssen Biotech Inc.
- Insulet Corporation
- Unilife Corporation
- West Pharmaceutical Services, Inc.
- Ypsomed
- Eli lilly and Company
- Haselmeier AG
- Alkermes
- AptarPharma
- Credence MedSystems, Inc.
- SchottAG
- Owen Mumford Ltd.
- Glide Technologies

View Full Report @ http://databridgemarketresearch.com/reports/global-self-injections-market-/

Scope of the Report:

The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography.

On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.

The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.

Based on therapeutic application, the global self-injections market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.

On the basis of route of administration, the global self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.

On the basis of end-user, the global self-injections market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.

Based on geography the global self-injections market is segmented into:

- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Rest of the World

For More Details In-Depth Inquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-self-injections-market

Key Topics Covered:

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL SELF-INJECTION MARKET, REGULATORY
7. GLOBAL SELF-INJECTION MARKET, REIMBUSEMENT
8. GLOBAL SELF-INJECTION MARKET, BY TYPE
9. GLOBAL SELF-INJECTION MARKET, BY APPLICATION
10. GLOBAL SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. GLOBAL SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. GLOBAL SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. GLOBAL SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
14. GLOBAL SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.3. EUROPE
14.4. APAC
14.5. SOUTH AMERICA
14.6. MEA
15. GLOBAL SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.3. SANOFI
16.4. SANDOZ INTERNATIONAL GMBH
16.6. UNILIFE CORPORATION
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.8. PFIZER INC.
16.9. IMPAX LABORATORIES, INC.
16.10. PENJET CORPORATION
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.13. ANTARES PHARMA
16.15. GERRESHEIMER AG
16.16. MYLAN N.V
16.17. NOVO NORDISK
16.18. OWEN MUMFORD LTD
16.19. PHARMAJET
16.20. SHL GROUP
16.21. YPSOMED
17. RELATED REPORTS

Related Report

Global Human Insulin Drugs and Delivery Devices Market – Industry Trends and Forecast to 2024

Global Human Insulin Drugs and Delivery Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-human-insulin-drugs-and-delivery-devices-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com